# RN1201 Injection for Autoimmune Diseases Refractory to Standard Therapies

> **NCT07105735** · PHASE1 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 18 (estimated)

## Conditions studied

- Autoimmune Diseases Refractory to Standard Therapies

## Interventions

- **BIOLOGICAL:** allogeneic CAR-T

## Key facts

- **NCT ID:** NCT07105735
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2027-08
- **Final completion:** 2027-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-08-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07105735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07105735, "RN1201 Injection for Autoimmune Diseases Refractory to Standard Therapies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07105735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*